Ascentage Pharma Group International
Price & Volume
Stats
See more52W Range | $16.50-$48.45 |
Market Cap | $6.3B |
Shares Short | 17,312 |
Financials
See moreRevenue (12 Mos) | $903M |
Revenue Growth (YoY) | 477.3% |
Gross Profit (12 Mos) | $875.5M |
Diluted EPS | -$0.17 |
News
See moreYahoo Finance • 2 months ago
Form 6K Ascentage Pharma Group Int Ltd For: 21 August
Yahoo Finance • 2 months ago
Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates
Yahoo Finance • 2 months ago
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
Yahoo Finance • 2 months ago
Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025
About
CEO | Dr. Dajun Yang M.D., Ph.D. |
Address | Suzhou Industrial Park, Suzhou, China, 215000 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 605 |
